Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study

Authors:

Abstract
No abstract available
Funding Information
  • Dainippon Sumitomo Pharma

This publication has 25 references indexed in Scilit: